JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Scope & Guideline

Empowering Open Access to Medicinal Insights

Introduction

Explore the comprehensive scope of JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1475-6366
PublisherTAYLOR & FRANCIS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1985 to 1996, from 1998 to 1999, from 2002 to 2024
AbbreviationJ ENZYM INHIB MED CH / J. Enzym. Inhib. Med. Chem.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The Journal of Enzyme Inhibition and Medicinal Chemistry primarily focuses on the discovery and development of enzyme inhibitors and their medicinal applications. The journal emphasizes the integration of synthetic chemistry, biological evaluation, and computational methods to advance drug discovery and therapeutic strategies.
  1. Enzyme Inhibition Research:
    The journal publishes articles that explore the mechanisms, efficacy, and selectivity of various enzyme inhibitors, focusing on their potential therapeutic applications in diseases such as cancer, diabetes, and infectious diseases.
  2. Medicinal Chemistry:
    Papers often highlight the design, synthesis, and biological evaluation of novel compounds that act as enzyme inhibitors, showcasing the intersection of chemistry and biological efficacy.
  3. Computational Drug Design and Molecular Modelling:
    The journal features studies that utilize computational methods, such as molecular docking and dynamics simulations, to predict the efficacy and selectivity of enzyme inhibitors, aiding in the rational design of new drugs.
  4. Natural Products and Derivatives:
    Research on natural compounds and their derivatives as enzyme inhibitors is prominently featured, emphasizing the exploration of traditional medicine and natural sources for novel therapeutic agents.
  5. Targeted and Multi-targeted Therapeutics:
    The journal explores the development of multi-targeted inhibitors that can simultaneously modulate multiple pathways, reflecting a growing trend in personalized medicine and complex disease treatment.
The Journal of Enzyme Inhibition and Medicinal Chemistry has identified several emerging trends reflecting the evolving landscape of enzyme inhibition research and medicinal chemistry.
  1. COVID-19 Therapeutics:
    There has been a significant increase in research focused on developing inhibitors targeting SARS-CoV-2, particularly through enzyme inhibition strategies, reflecting the urgency and relevance of this global health crisis.
  2. Dual and Multi-target Inhibitors:
    The trend towards discovering compounds that can inhibit multiple targets simultaneously is gaining momentum, as researchers seek to create more effective treatments that can address complex disease mechanisms.
  3. Artificial Intelligence and Machine Learning in Drug Discovery:
    Increasingly, studies are incorporating AI and machine learning techniques to enhance drug discovery processes, particularly in predicting the interactions and efficacy of enzyme inhibitors.
  4. Personalized Medicine Approaches:
    Research is increasingly focusing on tailoring therapies to individual patients' profiles, particularly in cancer treatment, which has led to a rise in studies on personalized enzyme inhibitors.
  5. Sustainable and Green Chemistry Practices:
    There is a growing emphasis on sustainable practices in the synthesis of enzyme inhibitors, including the use of environmentally friendly solvents and methodologies, reflecting wider trends in the scientific community towards sustainability.

Declining or Waning

While the journal continues to focus on a range of topics within enzyme inhibition and medicinal chemistry, certain themes have seen a decline in prominence or frequency in recent publications.
  1. Traditional Medicinal Approaches:
    Research focusing solely on traditional medicinal compounds without extensive modification or synthetic approaches appears to be declining, as more emphasis is placed on novel synthetic pathways and targeted therapies.
  2. Single-target Inhibitors:
    The trend towards developing inhibitors that target single enzymes is waning, with a noticeable shift towards multi-target inhibitors and combination therapies that address the complexity of diseases.
  3. Basic Mechanistic Studies:
    Although foundational studies on enzyme mechanisms remain important, there is less emphasis on purely mechanistic studies without therapeutic implications, as the journal increasingly prioritizes translational research.

Similar Journals

Journal of Molecular Structure

Advancing molecular insights for a dynamic future.
Publisher: ELSEVIERISSN: 0022-2860Frequency: 24 issues/year

Journal of Molecular Structure is a premier publication in the field of chemistry, offering a platform for innovative research that spans analytical, inorganic, organic chemistry, and spectroscopy. Published by Elsevier in the Netherlands, this journal is committed to advancing the understanding of molecular architecture and behavior through high-quality, peer-reviewed articles. With its impressive impact factor and a notable Scopus ranking placing it in the top quartiles among its peers, it serves as an essential resource for researchers, professionals, and students alike. The journal's open access options promote the dissemination of knowledge, ensuring that groundbreaking discoveries reach a broad audience. Established in 1967 and projected to continue through 2025, the Journal of Molecular Structure is vital for anyone engaged in the study of molecular interactions and structural analysis.

ARCHIV DER PHARMAZIE

Empowering Scholars with Timeless Pharmaceutical Insights
Publisher: WILEY-V C H VERLAG GMBHISSN: 0365-6233Frequency: 12 issues/year

ARCHIV DER PHARMAZIE is a prestigious journal published by WILEY-V C H VERLAG GMBH, dedicated to pioneering advances in the fields of Pharmaceutical Science and Drug Discovery. With an impactful history dating back to its inception in 1822, this journal is recognized for its significant contribution to the pharmaceutical sciences, maintaining an impressive Q2 ranking in both the Drug Discovery and Pharmaceutical Science categories as of 2023. The journal’s commitment to excellence is reflected in its Scopus rankings, placing it in the top tiers of relevant fields, ensuring a broad reach and impact among researchers and professionals. Although Open Access options are not available, ARCHIV DER PHARMAZIE continues to be an invaluable resource for scholars seeking to stay abreast of cutting-edge research and developments in pharmacy and related sciences. The journal’s contributions not only serve as crucial benchmarks in research but also enhance the understanding of pharmaceutical innovations, making it essential reading for both seasoned professionals and students alike.

MEDICINAL RESEARCH REVIEWS

Transforming Research into Revolutionary Therapeutics
Publisher: WILEYISSN: 0198-6325Frequency: 6 issues/year

MEDICINAL RESEARCH REVIEWS, published by Wiley, is a leading journal in the fields of Drug Discovery, Molecular Medicine, and Pharmacology. With an impressive impact factor and esteemed standing in its category quartiles (Q1 in all three fields), this journal serves as a vital platform for the dissemination of cutting-edge research and reviews that drive innovation in therapeutic development and molecular health sciences. Since its inception in 1981, MEDICINAL RESEARCH REVIEWS has garnered a robust readership within the scientific community, underscored by its high rankings in Scopus – where it ranks #3 in Pharmacology and #2 in Drug Discovery, placing it within the top echelons of academic influence. Researchers, professionals, and students alike benefit from its rich content and comprehensive approaches to tackling complex medicinal challenges, making it an essential resource for those invested in advancing the frontiers of biomedical research.

Future Medicinal Chemistry

Transforming challenges into opportunities in drug development.
Publisher: Newlands Press LtdISSN: 1756-8919Frequency: 24 issues/year

Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.

Journal of the Mexican Chemical Society

Pioneering Research for a Sustainable Chemical Future
Publisher: SOC QUIMICA MEXICOISSN: 1870-249XFrequency: 4 issues/year

Welcome to the Journal of the Mexican Chemical Society, an essential publication for researchers and professionals in the field of chemistry. Published by the reputable SOC QUIMICA MEXICO, this journal has been a vital platform for sharing innovative research and developments in the field since its inception in 2008. With an ISSN of 1870-249X and an E-ISSN of 1665-9686, the journal provides valuable insights and contributes to the global scientific community. As of 2023, it holds a Q3 quartile ranking in miscellaneous chemistry categories and ranks #258 out of 408 in General Chemistry on Scopus, placing it at the 36th percentile among its peers. Although currently not an open access journal, it remains committed to disseminating high-quality research that supports advancements in chemical education, practice, and technology. Researchers, academics, and students are encouraged to engage with this journal to explore groundbreaking studies and enhance their understanding of diverse chemical disciplines.

Fitoterapia

Bridging Nature and Innovation in Drug Discovery
Publisher: ELSEVIERISSN: 0367-326XFrequency: 8 issues/year

Fitoterapia is a prestigious journal published by Elsevier that specializes in the fields of drug discovery and pharmacology. Established in 1948 and featuring a comprehensive scope that encompasses all aspects of medicinal plants and their derivatives, this journal is a critical resource for researchers, professionals, and students interested in the pharmacological effects of natural products. With an impressive impact factor reflected in its Q2 ranking in both Drug Discovery and Medicine as well as a Q3 ranking in Pharmacology, Fitoterapia plays a vital role in promoting innovative research in the intersection of traditional medicine and modern pharmacological science. The journal’s commitment to quality is further highlighted by its rankings in Scopus, where it holds a notable position among peers in its field. Although Fitoterapia does not currently offer Open Access, its reputation for rigor and relevance makes it an indispensable asset for anyone engaged in herbal medicine research and development. Authors and researchers seeking to publish groundbreaking findings will find a welcoming platform to disseminate their work in this influential journal.

Records of Natural Products

Exploring the Essence of Nature's Pharmacy
Publisher: ACG PUBLICATIONSISSN: 1307-6167Frequency: 6 issues/year

Records of Natural Products is a distinguished journal focused on the dynamic fields of Drug Discovery, Organic Chemistry, Pharmacology, and Plant Science. Published by ACG PUBLICATIONS in Turkey, this journal serves as a vital platform for disseminating innovative research findings and advancements in natural product studies. With its convergence spanning from 2009 to 2024, Records of Natural Products holds a commendable position in the academic realm, featuring a 2023 Q3 ranking in Drug Discovery and Organic Chemistry, alongside a notable Q2 ranking in Plant Science. Despite its current lack of open access, the journal is committed to providing quality content that enriches the understanding of natural products and their potential applications. Researchers and professionals alike can benefit from the journal's insights, which not only contribute to scientific knowledge but also facilitate advancements in pharmaceuticals and sustainable practices. By exploring the rich tapestry of natural product research, this journal underscores its importance as a leading resource for professionals dedicated to enhancing the efficacy and application of natural compounds.

Letters in Drug Design & Discovery

Unveiling Novel Approaches in Drug Design & Discovery
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1808Frequency: 12 issues/year

Letters in Drug Design & Discovery is an esteemed journal dedicated to advancing the fields of Drug Discovery and Molecular Medicine. Published by Bentham Science Publishers, this journal offers a platform for the dissemination of innovative research and advanced methodologies, enhancing collaboration among researchers and professionals in pharmaceutical sciences. Despite its current Q4 ranking in Drug Discovery and Molecular Medicine and Q3 in Pharmaceutical Science for 2023, the journal is committed to improving its presence in the academic community by providing quality, peer-reviewed publications that cover various aspects of drug design and discovery, including novel therapeutic approaches and methodologies. With a focus on both foundational and cutting-edge research from around the globe, Letters in Drug Design & Discovery is pivotal for those seeking to stay abreast of developments in drug development and molecular research. Researchers are encouraged to submit their work, engage with the burgeoning field, and contribute to the ongoing dialogue driven by this journal, which spans the years from 2005 to 2024. While the journal does not currently offer open access, its contributions remain accessible to a wide range of academic and professional audiences.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Exploring breakthroughs in bioorganic science.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-894XFrequency: 24 issues/year

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, published by PERGAMON-ELSEVIER SCIENCE LTD, is a leading journal in the fields of biochemistry, drug discovery, and medicinal chemistry, designed to disseminate significant advances in these disciplines. Established in 1991, the journal spans various important categories, including Organic Chemistry and Pharmaceutical Science, with its 2023 Scimago Journal Rank placing it at Q2 in Organic Chemistry and Q3 in several other relevant fields. Though not an open-access publication, it provides invaluable insights into contemporary research and innovative methodologies, appealing to researchers, professionals, and students alike. The journal's commitment to quality and relevance makes it a vital resource for those aiming to stay at the forefront of bioorganic and medicinal chemistry developments. For more information, please visit the journal's website as it remains a critical platform for scholarly exchange, particularly for those engaged in interdisciplinary research.

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH

Advancing Knowledge in Natural Product Sciences
Publisher: TAYLOR & FRANCIS LTDISSN: 1028-6020Frequency: 12 issues/year

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH is a prestigious publication in the field of natural products, focusing on valuable research spanning analytical chemistry, pharmacology, and complementary medicine. Published by Taylor & Francis Ltd in the United Kingdom, this journal has established itself as a key resource for academics and professionals seeking to explore advancements in drug discovery and organic chemistry. With a converged publication timeline from 1998 to 2024, the journal boasts several commendable category quartiles as of 2023, reflecting its robust standing in the research community: Q2 in Complementary and Alternative Medicine, Q3 in multiple domains including Analytical Chemistry and Organic Chemistry, and Q4 in Molecular Medicine. Although it currently does not offer open access, the journal remains a valuable compendium for empirical research and innovative studies in areas such as pharmacology and medicinal chemistry. Researchers, professionals, and students alike will find the JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH to be an essential platform for sharing groundbreaking findings and fostering collaborations that lead to significant advancements in science and health.